Target intelligence / Profile preview

Short Ragweed (Ambrosia artemisiifolia) Pollen-Specific IgE-Mediated Immune Response (Ragweed IgE Response)

Target
Ragweed IgE Response
Molecular classification
Immune Response, Type I Hypersensitivity, Allergen-Specific IgE Response
01

Overview

The short ragweed (Ambrosia artemisiifolia) pollen-specific IgE-mediated immune response is a Type I hypersensitivity reaction triggered by exposure to ragweed pollen in sensitized individuals. This response involves the activation of Th2 lymphocytes, production of specific IgE antibodies, and subsequent release of inflammatory mediators from mast cells and basophils upon re-exposure to the allergen. The primary allergen, Amb a 1, plays a crucial role in this process. Management includes pharmacotherapy for symptom relief and allergen-specific immunotherapy to induce immune tolerance.

Other names
Ragweed AllergyAmbrosia artemisiifolia AllergyRagweed-induced Type I HypersensitivitySeasonal Allergic Rhinitis (Ragweed)Amb a 1-mediated allergy
02

Mechanism of action

Antihistamines block histamine receptors; Corticosteroids reduce inflammation; AIT induces immune tolerance.

03

Biological functions

Immune responseAllergic inflammationIgE productionMast cell activationTh2 cell activation
04

Disease associations

Allergic rhinitisAsthmaConjunctivitis
05

Safety considerations

Anaphylaxis (during AIT)Side effects of antihistamines (drowsiness)Side effects of corticosteroids (long-term use)
06

Interacting drugs

Antihistamines

2 more in the full profile.

07

Biomarkers

Ragweed-specific IgE levelsTotal IgE levelsEosinophil countAmb a 1-specific T cell responses

Beyond the preview

Go deeper on Short Ragweed (Ambrosia artemisiifolia) Pollen-Specific IgE-Mediated Immune Response (Ragweed IgE Response).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Short Ragweed (Ambrosia artemisiifolia) Pollen-Specific IgE-Mediated Immune Response (Ragweed IgE Response).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call